LYNNE ARMIGER: Open Payments
NPI 1346557048 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$595 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $315 · 2025 $595
Food & beverage: $595
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $157 |
| CeQur Corporation | 1 | $104 |
| Lilly USA, LLC | 4 | $81 |
| Novo Nordisk Inc | 4 | $74 |
| Medtronic, Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $40 |
| Insulet Corporation | 1 | $28 |
| Averitas Pharma Inc. | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Sequel Med Tech, LLC | 1 | $16 |
Products named: Kerendia, CeQur Simplicity, MOUNJARO, Rybelsus, Ozempic, MINIMED 780G, Omnipod, QUTENZA.
Industry payments across MD — which companies pay providers there.
